bioshares report october 2007, page-17

dma;
Re. take-over,
VCR outstanding shares = approx 285,000,000
At $1.00 per share = $285,000,000
At $100,000 per device = 2,850 implants

This means whoever takes vcr over will need to perform 2,850 implants to re-coup investment before realising profit. If vcr can perform 600 impants per year, AFTER APPROVAL FROM FDA, this means a little under 5 years are required to re-coup take-over costs!!!!!!!!

All this at the price of $1.00 per share!!!!!.........If vcr gets FDA, the price will be worth more than $1.00!!!!

Take-over???!!!....from this angle, the numbers are not talking!!!

Please refer to previous posts re. TETS. If it is true, vcr are including it into the BTT and DT trials, then yes, this will be Kick-A^$e news. Which means more $$$$$, which means the above formula becomes much more expensive!!!!

Good strong finish today. First price target reached. Next one is 0.71 cents!!!!...Time will tell.

Cheers;
Vyking